Skip to content

Rotational Atherectomy Combined With Cutting Balloon to Optimize Stent Expansion in Calcified Lesions

Rotational Atherectomy Combined With Cutting Balloon to Optimize Stent Expansion in Calcified Lesions

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04865588
Acronym
ROTA-CUT
Enrollment
60
Registered
2021-04-29
Start date
2022-05-13
Completion date
2023-12-12
Last updated
2024-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Atherosclerosis

Keywords

calcified plaque, angioplasty, cutting balloon

Brief summary

Rotational atherectomy is an established tool to treat blocked arteries in the heart, in which the blockage is due to significant amounts of calcified material. In rotational atherectomy, a rotating instrument is used to break up the calcification before a stent is placed and helps restore blood flow to the heart. However, severely calcified regions are difficult to treat and even after treatment arteries can re-clog and major cardiac events occur. This study will test if rotational atherectomy with the addition of a cutting balloon - a balloon with microsurgical blades on its outer surface which make longitudinal incisions in the calcified area in order to open resistant clogs - will result in increased blood vessel lumen, more optimal stent expansion and decreased cardiac problems compared to current standard treatment.

Detailed description

This is a prospective, pilot study randomizing patients with stable Coronary Artery Disease undergoing Percutaneous Coronary Intervention for a de novo calcified lesion with drug eluting stent implantation to angioplasty with rotational atherectomy followed by cutting balloon (ROTA + CBA) or rotational atherectomy followed by plain old balloon (ROTA + POBA) in a 1:1 ratio. The clinical investigation will be conducted at 2 centers in the US. Up to 48 randomized subjects per site will be enrolled in this study. Subjects participating in this clinical investigation will be followed for 9 months. The expected duration of enrollment is approximately 6 months. The total duration of the clinical investigation is expected to be approximately 2 years.

Interventions

angioplasty with rotational atherectomy - a rotating instrument used to break up the calcification

a balloon with microsurgical blades on its outer surface which make longitudinal incisions in the calcified area in order to open resistant clogs

DEVICEplain old balloon

current standard treatment of stent placement

Sponsors

Samin Sharma, M.D., F.A.C.C., M.S.C.A.I.
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Parallel Assignment

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults Patients ≥18 years of age * Patients undergoing percutaneous coronary intervention with planned rotational atherectomy and planned drug-eluting stent implantation of a lesion with target vessel reference diameter ≥2.5 mm and ≤ 4.0mm, lesion length ≥ 5 mm and moderate to severe calcification by angiography * Patients eligible for percutaneous coronary intervention

Exclusion criteria

* Patients in cardiogenic shock * Planned surgery (cardiac and non-cardiac) within 6 months after the index procedure unless the dual-antiplatelet therapy can be maintained throughout the perisurgical period * Patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction * Subject is pregnant, nursing, or is a woman of child-bearing potential who is not surgically sterile, \< 2 years postmenopausal, or does not consistently use effective methods of contraception * Patient has any other serious medical illness (e.g., cancer, end-stage congestive heart failure) that may reduce life expectancy to less than 12 months * Currently participating in another investigational drug or device study * Patients referred to coronary artery bypass grafting after heart team discussion Angiographic Specific

Design outcomes

Primary

MeasureTime frameDescription
Minimum Stent Area After Percutaneous Coronary InterventionPost-procedure, Day 0Post-procedure minimum stent area after percutaneous coronary intervention assessed by intravascular ultrasound (IVUS)

Secondary

MeasureTime frameDescription
Number of Participants Who Died of Non-Cardiac Death After Percutaneous Coronary Intervention30 daysNon-Cardiac Death
In-segment Minimum Lumen Area After Stent Implantation and Post DilatationPost-procedure, Day 0In-segment Minimum lumen area after stent implantation and post dilatation assessed by intravascular ultrasound
Minimum Percent Stent Expansion After Percutaneous Coronary InterventionPost-procedure, Day 0Minimum percent stent expansion after Percutaneous Coronary Intervention assessed by intravascular ultrasound
Mean Percent Stent Expansion After Percutaneous Coronary InterventionPost-procedure, Day 0Mean percent stent expansion after percutaneous coronary intervention assessed by intravascular ultrasound
Number of Participants With Dissection After Percutaneous Coronary InterventionPost-procedure, Day 0Number of Participants with Dissection after Percutaneous Coronary Intervention assessed by intravascular ultrasound.
Number of Participants With Stent Malapposition After Percutaneous Coronary InterventionPost-Procedure, Day 0Number of Participants with Stent malapposition after Percutaneous Coronary Intervention assessed by intravascular ultrasound. Malapposition is indicated by blood visible behind stent struts. Stents may be completely or only partially malapposed depending on how much of the stent is in contact with the lumen wall.
Number of Participants With Dissection After Rotational Atherectomy and Cutting Balloon Angioplasty /Non-compliant Balloon Angioplasty (CBA/NCBA)Post-CBA/NCBA before stent, Day 0Number of Participants with Dissection after Rotational atherectomy and cutting balloon angioplasty /non-compliant balloon angioplasty (CBA/NCBA) assessed by intravascular ultrasound. A dissection or tear in the vessel wall
Number of Participants With a Calcium Fracture After Rotational Atherectomy and Cutting/Plain Old BalloonPost-Procedure, Day 0Number of Participants with a Calcium fracture after Rotational atherectomy and Cutting/Plain old balloon assessed by intravascular ultrasound. A fracture within the calcified area.
Acute Lumen Gain In-segment After Stent Implantation Assessed by AngiographyPost-procedure, Day 0Defined as the minimal luminal diameter in stent after stent implantation minus the minimal luminal diameter at baseline (prior to percutaneous coronary intervention and/or prior to stent placement).
Acute Lumen Gain In-stent After Stent Implantation Assessed by AngiographyPost-procedure, Day 0Defined as the minimal luminal diameter in segment after stent implantation minus the minimal luminal diameter at baseline (prior to percutaneous coronary intervention and/or prior to stent placement).
Percent Residual Diameter Stenosis In-segment After Stent ImplantationPost-procedure, Day 0Percent Residual diameter stenosis in-segment after stent implantation assessed by Angiography
Percent Residual Diameter Stenosis In-stent After Stent ImplantationPost-procedure, Day 0Percent Residual diameter stenosis in-stent after stent implantation assessed by Angiography
Minimum Lumen Diameter In-segment After Stent ImplantationPost-procedure, Day 0Minimum lumen diameter in-segment after stent implantation assessed by Angiography
Minimum Lumen Diameter In-stent After Stent ImplantationPost-procedure, Day 0Minimum lumen diameter in-stent after stent implantation assessed by Angiography
Number of Participants Who Died of Cardiac Death After Percutaneous Coronary Intervention30 daysCardiac Death
Number of Participants With Perforation (Ellis Type ≥2) After Stent ImplantationPost-procedure, Day 0Number of Participants with perforation (Ellis type ≥2) after stent implantation assessed by Angiography. Perforation of a vessel
Number of Participants With Side Branch Closure After Stent ImplantationPost-procedure, Day 0Number of Participants with side branch closure after stent implantation assessed by Angiography. Occlusion of a side branch
Number of Participants With a Balloon RupturePost-Procedure, Day 0Device problem; Rupture of the cutting balloon or plain old balloon
Number of Participants With Blade DetachmentPost-Procedure, Day 0Device problem; detachment of a blade from the cutting balloon
Number of Participants With Difficulty in Withdrawing/Advancing the DevicePost-Procedure, Day 0Device problem; difficulty in moving the balloon within the vessel during the procedure
Number of Participants Who Died of All-causes (Cardiac and Non-cardiac) After Percutaneous Coronary Intervention30 days
Number of Participants With Myocardial Infarction, as Defined by the Society for Cardiovascular Angiography and Intervention (SCAI), After Percutaneous Coronary Intervention30 daysThe Society for Cardiovascular Angiography and Intervention (SCAI) defines clinically relevant MI after PCI as an elevation of cardiac biomarkers (CK-MB or troponin) above specified thresholds within 48 hours of the procedure, with or without new Q waves or LBBB on ECG. This definition aims to identify meaningful ischemic injury to the myocardium that is associated with adverse clinical outcomes.
Percent of Participants With Myocardial Infarction, as Defined by 4th Universal Definition, After Percutaneous Coronary Intervention30 daysMyocardial infarction is defined as heart muscle damage due to lack of blood flow, based on characteristic symptoms, ECG changes, and cardiac biomarker elevation, especially troponin. Elevated levels of cardiac biomarkers, especially troponin, along with ECG changes and cardiac symptoms, indicate myocardial infarction according to the universal definition.
Number of Participants With Target Lesion Revascularization After Percutaneous Coronary Intervention30 daysRevascularization
Number of Participants With Target Vessel Revascularization After Percutaneous Coronary Intervention30 daysRevascularization
Number of Participants With Stent Thrombosis (Definite/Probable) After Percutaneous Coronary Intervention30 daysStent Thrombosis
Number of Participants With Major Bleeding (BARC 3 or 5) After Percutaneous Coronary Intervention30 daysBleeding Academic Research Consortium (BARC) Type 3 1. Overt bleeding plus hemoglobin drop of 3 to \< 5 g/dL (provided hemoglobin drop is related to bleed); transfusion with overt bleeding 2. Overt bleeding plus hemoglobin drop \< 5 g/dL (provided hemoglobin drop is related to bleed); cardiac tamponade; bleeding requiring surgical intervention for control; bleeding requiring IV vasoactive agents 3. Intracranial hemorrhage confirmed by autopsy, imaging, or lumbar puncture; intraocular bleed compromising vision Type 5 1. Probable fatal bleeding 2. Definite fatal bleeding (overt or autopsy or imaging confirmation)
Number of Participants With Vascular Complications After Percutaneous Coronary Intervention30 daysVascular complication
Angina Status According to Canadian Cardiovascular Society (CSS) Classification270 daysThe Canadian Cardiovascular Society (CCS) grading scale is a classification system used to grade the severity of angina pectoris based on symptoms and their relationship to physical activity. Grade I: Ordinary physical activity like walking does not cause angina. Angina only occurs with strenuous, rapid, prolonged exertion during recreation or work. Grade II: Slight limitation of ordinary activity. Angina occurs when walking/climbing stairs rapidly, walking uphill, after meals, in cold/wind, under stress, or early morning. Angina occurs when walking more than 2 blocks or climbing more than 1 flight of stairs at a normal pace. Grade III: Marked limitation of ordinary activity. Angina occurs when walking 1-2 blocks or climbing 1 flight of stairs at a normal pace. Grade IV: Inability to carry out any physical activity without angina. Anginal symptoms may be present at rest. Higher grades indicate more limitations to activity due to angina.
Number of Participants With Dissection Type B or GreaterPost-CBA/NCBA before stent and after stent, Day 0Number of Participants with Dissection Type B or greater before and after stent implantation assessed by Angiography.

Countries

United States

Participant flow

Participants by arm

ArmCount
Rotational Atherectomy + Cutting Balloon
angioplasty with rotational atherectomy followed by cutting balloon rotational atherectomy: angioplasty with rotational atherectomy - a rotating instrument used to break up the calcification cutting balloon: a balloon with microsurgical blades on its outer surface which make longitudinal incisions in the calcified area in order to open resistant clogs
29
Rotational Atherectomy + Plain Old Balloon
angioplasty with rotational atherectomy followed by plain old balloon rotational atherectomy: angioplasty with rotational atherectomy - a rotating instrument used to break up the calcification plain old balloon: current standard treatment of stent placement
31
Total60

Baseline characteristics

CharacteristicRotational Atherectomy + Cutting BalloonRotational Atherectomy + Plain Old BalloonTotal
Age, Continuous69.2 years
STANDARD_DEVIATION 10
72.8 years
STANDARD_DEVIATION 8.7
71.1 years
STANDARD_DEVIATION 9.4
Cerebrovascular disease3 Participants5 Participants8 Participants
Chronic renal insufficiency5 Participants2 Participants7 Participants
Current smoker3 Participants6 Participants9 Participants
Diabetes mellitus12 Participants13 Participants25 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants4 Participants8 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
25 Participants27 Participants52 Participants
Family history of coronary artery disease (CAD)15 Participants18 Participants33 Participants
Hyperlipidaemia28 Participants29 Participants57 Participants
Hypertension28 Participants29 Participants57 Participants
Insulin6 Participants5 Participants11 Participants
Left ventricular ejection fraction (LVEF)55.6 percent
STANDARD_DEVIATION 9.8
57.3 percent
STANDARD_DEVIATION 7.6
56.5 percent
STANDARD_DEVIATION 8.7
Peripheral arterial disease4 Participants3 Participants7 Participants
Prior coronary artery bypass grafting (CABG)2 Participants2 Participants4 Participants
Prior myocardial infarction (MI)4 Participants7 Participants11 Participants
Prior percutaneous coronary intervention (PCI)20 Participants20 Participants40 Participants
Prior stroke1 Participants2 Participants3 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
10 Participants5 Participants15 Participants
Race (NIH/OMB)
Black or African American
3 Participants1 Participants4 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Unknown or Not Reported
4 Participants4 Participants8 Participants
Race (NIH/OMB)
White
12 Participants20 Participants32 Participants
Sex: Female, Male
Female
8 Participants5 Participants13 Participants
Sex: Female, Male
Male
21 Participants26 Participants47 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 290 / 31
other
Total, other adverse events
24 / 2928 / 31
serious
Total, serious adverse events
4 / 294 / 31

Outcome results

Primary

Minimum Stent Area After Percutaneous Coronary Intervention

Post-procedure minimum stent area after percutaneous coronary intervention assessed by intravascular ultrasound (IVUS)

Time frame: Post-procedure, Day 0

ArmMeasureValue (MEAN)Dispersion
Rotational Atherectomy + Cutting BalloonMinimum Stent Area After Percutaneous Coronary Intervention6.7 mm^2Standard Deviation 1.7
Rotational Atherectomy + Plain Old BalloonMinimum Stent Area After Percutaneous Coronary Intervention6.9 mm^2Standard Deviation 1.8
Secondary

Acute Lumen Gain In-segment After Stent Implantation Assessed by Angiography

Defined as the minimal luminal diameter in stent after stent implantation minus the minimal luminal diameter at baseline (prior to percutaneous coronary intervention and/or prior to stent placement).

Time frame: Post-procedure, Day 0

ArmMeasureValue (MEAN)Dispersion
Rotational Atherectomy + Cutting BalloonAcute Lumen Gain In-segment After Stent Implantation Assessed by Angiography1.0 mmStandard Deviation 0.4
Rotational Atherectomy + Plain Old BalloonAcute Lumen Gain In-segment After Stent Implantation Assessed by Angiography1.1 mmStandard Deviation 0.3
Secondary

Acute Lumen Gain In-stent After Stent Implantation Assessed by Angiography

Defined as the minimal luminal diameter in segment after stent implantation minus the minimal luminal diameter at baseline (prior to percutaneous coronary intervention and/or prior to stent placement).

Time frame: Post-procedure, Day 0

ArmMeasureValue (MEAN)Dispersion
Rotational Atherectomy + Cutting BalloonAcute Lumen Gain In-stent After Stent Implantation Assessed by Angiography1.5 mmStandard Deviation 0.3
Rotational Atherectomy + Plain Old BalloonAcute Lumen Gain In-stent After Stent Implantation Assessed by Angiography1.6 mmStandard Deviation 0.4
Secondary

Angina Status According to Canadian Cardiovascular Society (CSS) Classification

The Canadian Cardiovascular Society (CCS) grading scale is a classification system used to grade the severity of angina pectoris based on symptoms and their relationship to physical activity. Grade I: Ordinary physical activity like walking does not cause angina. Angina only occurs with strenuous, rapid, prolonged exertion during recreation or work. Grade II: Slight limitation of ordinary activity. Angina occurs when walking/climbing stairs rapidly, walking uphill, after meals, in cold/wind, under stress, or early morning. Angina occurs when walking more than 2 blocks or climbing more than 1 flight of stairs at a normal pace. Grade III: Marked limitation of ordinary activity. Angina occurs when walking 1-2 blocks or climbing 1 flight of stairs at a normal pace. Grade IV: Inability to carry out any physical activity without angina. Anginal symptoms may be present at rest. Higher grades indicate more limitations to activity due to angina.

Time frame: 270 days

Secondary

In-segment Minimum Lumen Area After Stent Implantation and Post Dilatation

In-segment Minimum lumen area after stent implantation and post dilatation assessed by intravascular ultrasound

Time frame: Post-procedure, Day 0

ArmMeasureValue (MEAN)Dispersion
Rotational Atherectomy + Cutting BalloonIn-segment Minimum Lumen Area After Stent Implantation and Post Dilatation5.9 mm^2Standard Deviation 1.4
Rotational Atherectomy + Plain Old BalloonIn-segment Minimum Lumen Area After Stent Implantation and Post Dilatation6.4 mm^2Standard Deviation 1.9
Secondary

Mean Percent Stent Expansion After Percutaneous Coronary Intervention

Mean percent stent expansion after percutaneous coronary intervention assessed by intravascular ultrasound

Time frame: Post-procedure, Day 0

ArmMeasureValue (MEAN)Dispersion
Rotational Atherectomy + Cutting BalloonMean Percent Stent Expansion After Percutaneous Coronary Intervention112.5 mean percent expansionStandard Deviation 19.4
Rotational Atherectomy + Plain Old BalloonMean Percent Stent Expansion After Percutaneous Coronary Intervention104.2 mean percent expansionStandard Deviation 13.5
Secondary

Minimum Lumen Diameter In-segment After Stent Implantation

Minimum lumen diameter in-segment after stent implantation assessed by Angiography

Time frame: Post-procedure, Day 0

ArmMeasureValue (MEAN)Dispersion
Rotational Atherectomy + Cutting BalloonMinimum Lumen Diameter In-segment After Stent Implantation2.1 mmStandard Deviation 0.3
Rotational Atherectomy + Plain Old BalloonMinimum Lumen Diameter In-segment After Stent Implantation2.1 mmStandard Deviation 0.4
Secondary

Minimum Lumen Diameter In-stent After Stent Implantation

Minimum lumen diameter in-stent after stent implantation assessed by Angiography

Time frame: Post-procedure, Day 0

ArmMeasureValue (MEAN)Dispersion
Rotational Atherectomy + Cutting BalloonMinimum Lumen Diameter In-stent After Stent Implantation2.5 mmStandard Deviation 0.3
Rotational Atherectomy + Plain Old BalloonMinimum Lumen Diameter In-stent After Stent Implantation2.5 mmStandard Deviation 0.4
Secondary

Minimum Percent Stent Expansion After Percutaneous Coronary Intervention

Minimum percent stent expansion after Percutaneous Coronary Intervention assessed by intravascular ultrasound

Time frame: Post-procedure, Day 0

ArmMeasureValue (MEAN)Dispersion
Rotational Atherectomy + Cutting BalloonMinimum Percent Stent Expansion After Percutaneous Coronary Intervention86.1 minimum percent expansionStandard Deviation 17.5
Rotational Atherectomy + Plain Old BalloonMinimum Percent Stent Expansion After Percutaneous Coronary Intervention78.6 minimum percent expansionStandard Deviation 14.7
Secondary

Number of Participants Who Died of All-causes (Cardiac and Non-cardiac) After Percutaneous Coronary Intervention

Time frame: 30 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Rotational Atherectomy + Cutting BalloonNumber of Participants Who Died of All-causes (Cardiac and Non-cardiac) After Percutaneous Coronary Intervention0 Participants
Rotational Atherectomy + Plain Old BalloonNumber of Participants Who Died of All-causes (Cardiac and Non-cardiac) After Percutaneous Coronary Intervention0 Participants
Secondary

Number of Participants Who Died of Cardiac Death After Percutaneous Coronary Intervention

Cardiac Death

Time frame: 30 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Rotational Atherectomy + Cutting BalloonNumber of Participants Who Died of Cardiac Death After Percutaneous Coronary Intervention0 Participants
Rotational Atherectomy + Plain Old BalloonNumber of Participants Who Died of Cardiac Death After Percutaneous Coronary Intervention0 Participants
Secondary

Number of Participants Who Died of Non-Cardiac Death After Percutaneous Coronary Intervention

Non-Cardiac Death

Time frame: 30 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Rotational Atherectomy + Cutting BalloonNumber of Participants Who Died of Non-Cardiac Death After Percutaneous Coronary Intervention0 Participants
Rotational Atherectomy + Plain Old BalloonNumber of Participants Who Died of Non-Cardiac Death After Percutaneous Coronary Intervention0 Participants
Secondary

Number of Participants With a Balloon Rupture

Device problem; Rupture of the cutting balloon or plain old balloon

Time frame: Post-Procedure, Day 0

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Rotational Atherectomy + Cutting BalloonNumber of Participants With a Balloon Rupture0 Participants
Rotational Atherectomy + Plain Old BalloonNumber of Participants With a Balloon Rupture0 Participants
Secondary

Number of Participants With a Calcium Fracture After Rotational Atherectomy and Cutting/Plain Old Balloon

Number of Participants with a Calcium fracture after Rotational atherectomy and Cutting/Plain old balloon assessed by intravascular ultrasound. A fracture within the calcified area.

Time frame: Post-Procedure, Day 0

Population: one participant missing imaging for this outcome measure

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Rotational Atherectomy + Cutting BalloonNumber of Participants With a Calcium Fracture After Rotational Atherectomy and Cutting/Plain Old Balloon14 Participants
Rotational Atherectomy + Plain Old BalloonNumber of Participants With a Calcium Fracture After Rotational Atherectomy and Cutting/Plain Old Balloon7 Participants
Secondary

Number of Participants With Blade Detachment

Device problem; detachment of a blade from the cutting balloon

Time frame: Post-Procedure, Day 0

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Rotational Atherectomy + Cutting BalloonNumber of Participants With Blade Detachment0 Participants
Rotational Atherectomy + Plain Old BalloonNumber of Participants With Blade Detachment0 Participants
Secondary

Number of Participants With Difficulty in Withdrawing/Advancing the Device

Device problem; difficulty in moving the balloon within the vessel during the procedure

Time frame: Post-Procedure, Day 0

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Rotational Atherectomy + Cutting BalloonNumber of Participants With Difficulty in Withdrawing/Advancing the Device0 Participants
Rotational Atherectomy + Plain Old BalloonNumber of Participants With Difficulty in Withdrawing/Advancing the Device0 Participants
Secondary

Number of Participants With Dissection After Percutaneous Coronary Intervention

Number of Participants with Dissection after Percutaneous Coronary Intervention assessed by intravascular ultrasound.

Time frame: Post-procedure, Day 0

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Rotational Atherectomy + Cutting BalloonNumber of Participants With Dissection After Percutaneous Coronary Intervention1 Participants
Rotational Atherectomy + Plain Old BalloonNumber of Participants With Dissection After Percutaneous Coronary Intervention3 Participants
Secondary

Number of Participants With Dissection After Rotational Atherectomy and Cutting Balloon Angioplasty /Non-compliant Balloon Angioplasty (CBA/NCBA)

Number of Participants with Dissection after Rotational atherectomy and cutting balloon angioplasty /non-compliant balloon angioplasty (CBA/NCBA) assessed by intravascular ultrasound. A dissection or tear in the vessel wall

Time frame: Post-CBA/NCBA before stent, Day 0

Population: one participant missing imaging for this outcome measure

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Rotational Atherectomy + Cutting BalloonNumber of Participants With Dissection After Rotational Atherectomy and Cutting Balloon Angioplasty /Non-compliant Balloon Angioplasty (CBA/NCBA)27 Participants
Rotational Atherectomy + Plain Old BalloonNumber of Participants With Dissection After Rotational Atherectomy and Cutting Balloon Angioplasty /Non-compliant Balloon Angioplasty (CBA/NCBA)30 Participants
Secondary

Number of Participants With Dissection Type B or Greater

Number of Participants with Dissection Type B or greater before and after stent implantation assessed by Angiography.

Time frame: Post-CBA/NCBA before stent and after stent, Day 0

Population: three participants missing imaging for this outcome measure

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Rotational Atherectomy + Cutting BalloonNumber of Participants With Dissection Type B or GreaterPost-CBA/NCBA before stent6 Participants
Rotational Atherectomy + Cutting BalloonNumber of Participants With Dissection Type B or GreaterPost-CBA/NCBA after stent0 Participants
Rotational Atherectomy + Plain Old BalloonNumber of Participants With Dissection Type B or GreaterPost-CBA/NCBA before stent13 Participants
Rotational Atherectomy + Plain Old BalloonNumber of Participants With Dissection Type B or GreaterPost-CBA/NCBA after stent1 Participants
Secondary

Number of Participants With Major Bleeding (BARC 3 or 5) After Percutaneous Coronary Intervention

Bleeding Academic Research Consortium (BARC) Type 3 1. Overt bleeding plus hemoglobin drop of 3 to \< 5 g/dL (provided hemoglobin drop is related to bleed); transfusion with overt bleeding 2. Overt bleeding plus hemoglobin drop \< 5 g/dL (provided hemoglobin drop is related to bleed); cardiac tamponade; bleeding requiring surgical intervention for control; bleeding requiring IV vasoactive agents 3. Intracranial hemorrhage confirmed by autopsy, imaging, or lumbar puncture; intraocular bleed compromising vision Type 5 1. Probable fatal bleeding 2. Definite fatal bleeding (overt or autopsy or imaging confirmation)

Time frame: 30 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Rotational Atherectomy + Cutting BalloonNumber of Participants With Major Bleeding (BARC 3 or 5) After Percutaneous Coronary Intervention0 Participants
Rotational Atherectomy + Plain Old BalloonNumber of Participants With Major Bleeding (BARC 3 or 5) After Percutaneous Coronary Intervention0 Participants
Secondary

Number of Participants With Myocardial Infarction, as Defined by the Society for Cardiovascular Angiography and Intervention (SCAI), After Percutaneous Coronary Intervention

The Society for Cardiovascular Angiography and Intervention (SCAI) defines clinically relevant MI after PCI as an elevation of cardiac biomarkers (CK-MB or troponin) above specified thresholds within 48 hours of the procedure, with or without new Q waves or LBBB on ECG. This definition aims to identify meaningful ischemic injury to the myocardium that is associated with adverse clinical outcomes.

Time frame: 30 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Rotational Atherectomy + Cutting BalloonNumber of Participants With Myocardial Infarction, as Defined by the Society for Cardiovascular Angiography and Intervention (SCAI), After Percutaneous Coronary Intervention1 Participants
Rotational Atherectomy + Plain Old BalloonNumber of Participants With Myocardial Infarction, as Defined by the Society for Cardiovascular Angiography and Intervention (SCAI), After Percutaneous Coronary Intervention0 Participants
Secondary

Number of Participants With Perforation (Ellis Type ≥2) After Stent Implantation

Number of Participants with perforation (Ellis type ≥2) after stent implantation assessed by Angiography. Perforation of a vessel

Time frame: Post-procedure, Day 0

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Rotational Atherectomy + Cutting BalloonNumber of Participants With Perforation (Ellis Type ≥2) After Stent Implantation0 Participants
Rotational Atherectomy + Plain Old BalloonNumber of Participants With Perforation (Ellis Type ≥2) After Stent Implantation0 Participants
Secondary

Number of Participants With Side Branch Closure After Stent Implantation

Number of Participants with side branch closure after stent implantation assessed by Angiography. Occlusion of a side branch

Time frame: Post-procedure, Day 0

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Rotational Atherectomy + Cutting BalloonNumber of Participants With Side Branch Closure After Stent Implantation0 Participants
Rotational Atherectomy + Plain Old BalloonNumber of Participants With Side Branch Closure After Stent Implantation0 Participants
Secondary

Number of Participants With Stent Malapposition After Percutaneous Coronary Intervention

Number of Participants with Stent malapposition after Percutaneous Coronary Intervention assessed by intravascular ultrasound. Malapposition is indicated by blood visible behind stent struts. Stents may be completely or only partially malapposed depending on how much of the stent is in contact with the lumen wall.

Time frame: Post-Procedure, Day 0

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Rotational Atherectomy + Cutting BalloonNumber of Participants With Stent Malapposition After Percutaneous Coronary Intervention5 Participants
Rotational Atherectomy + Plain Old BalloonNumber of Participants With Stent Malapposition After Percutaneous Coronary Intervention9 Participants
Secondary

Number of Participants With Stent Thrombosis (Definite/Probable) After Percutaneous Coronary Intervention

Stent Thrombosis

Time frame: 30 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Rotational Atherectomy + Cutting BalloonNumber of Participants With Stent Thrombosis (Definite/Probable) After Percutaneous Coronary Intervention0 Participants
Rotational Atherectomy + Plain Old BalloonNumber of Participants With Stent Thrombosis (Definite/Probable) After Percutaneous Coronary Intervention0 Participants
Secondary

Number of Participants With Target Lesion Revascularization After Percutaneous Coronary Intervention

Revascularization

Time frame: 30 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Rotational Atherectomy + Cutting BalloonNumber of Participants With Target Lesion Revascularization After Percutaneous Coronary Intervention1 Participants
Rotational Atherectomy + Plain Old BalloonNumber of Participants With Target Lesion Revascularization After Percutaneous Coronary Intervention0 Participants
Secondary

Number of Participants With Target Vessel Revascularization After Percutaneous Coronary Intervention

Revascularization

Time frame: 30 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Rotational Atherectomy + Cutting BalloonNumber of Participants With Target Vessel Revascularization After Percutaneous Coronary Intervention1 Participants
Rotational Atherectomy + Plain Old BalloonNumber of Participants With Target Vessel Revascularization After Percutaneous Coronary Intervention0 Participants
Secondary

Number of Participants With Vascular Complications After Percutaneous Coronary Intervention

Vascular complication

Time frame: 30 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Rotational Atherectomy + Cutting BalloonNumber of Participants With Vascular Complications After Percutaneous Coronary Intervention0 Participants
Rotational Atherectomy + Plain Old BalloonNumber of Participants With Vascular Complications After Percutaneous Coronary Intervention0 Participants
Secondary

Percent of Participants With Myocardial Infarction, as Defined by 4th Universal Definition, After Percutaneous Coronary Intervention

Myocardial infarction is defined as heart muscle damage due to lack of blood flow, based on characteristic symptoms, ECG changes, and cardiac biomarker elevation, especially troponin. Elevated levels of cardiac biomarkers, especially troponin, along with ECG changes and cardiac symptoms, indicate myocardial infarction according to the universal definition.

Time frame: 30 days

ArmMeasureValue (NUMBER)
Rotational Atherectomy + Cutting BalloonPercent of Participants With Myocardial Infarction, as Defined by 4th Universal Definition, After Percutaneous Coronary Intervention26.9 percent of participants
Rotational Atherectomy + Plain Old BalloonPercent of Participants With Myocardial Infarction, as Defined by 4th Universal Definition, After Percutaneous Coronary Intervention13.2 percent of participants
Secondary

Percent Residual Diameter Stenosis In-segment After Stent Implantation

Percent Residual diameter stenosis in-segment after stent implantation assessed by Angiography

Time frame: Post-procedure, Day 0

ArmMeasureValue (MEAN)Dispersion
Rotational Atherectomy + Cutting BalloonPercent Residual Diameter Stenosis In-segment After Stent Implantation25.8 percent residual diameter stenosisStandard Deviation 8.6
Rotational Atherectomy + Plain Old BalloonPercent Residual Diameter Stenosis In-segment After Stent Implantation28.4 percent residual diameter stenosisStandard Deviation 6.8
Secondary

Percent Residual Diameter Stenosis In-stent After Stent Implantation

Percent Residual diameter stenosis in-stent after stent implantation assessed by Angiography

Time frame: Post-procedure, Day 0

ArmMeasureValue (MEAN)Dispersion
Rotational Atherectomy + Cutting BalloonPercent Residual Diameter Stenosis In-stent After Stent Implantation13.8 percent residual diameter stenosisStandard Deviation 6.5
Rotational Atherectomy + Plain Old BalloonPercent Residual Diameter Stenosis In-stent After Stent Implantation14.8 percent residual diameter stenosisStandard Deviation 6.1

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026